| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.4M | +25.5% |
| SG&A Expense | $8.3M | +76.0% |
| Operating Income | -$55.7M | -31.1% |
| Pre-tax Income | -$45.3M | -17.5% |
| Income Tax | $235K | +834.4% |
| Net Income | -$45.5M | -18.2% |
| EPS (Basic) | -$1.49 | -18.3% |
| EPS (Diluted) | -$1.49 | -18.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125.6M | -27.3% |
| Current Assets | $127.0M | -27.3% |
| Total Assets | $150.1M | -24.6% |
| Current Liabilities | $7.9M | -47.5% |
| Total Liabilities | $9.7M | -42.2% |
| Stockholders' Equity | $140.3M | -23.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.9M | -28.9% |
| Capital Expenditures | $289K | -77.8% |
| Investing Cash Flow | -$289K | +77.8% |
| Financing Cash Flow | -$10.3M | -198.1% |
| Free Cash Flow | -$40.2M | -24.6% |